| __timestamp | Geron Corporation | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 9335772 |
| Thursday, January 1, 2015 | 17793000 | 12390000 |
| Friday, January 1, 2016 | 18761000 | 25602000 |
| Sunday, January 1, 2017 | 19287000 | 21262000 |
| Monday, January 1, 2018 | 18707000 | 28430000 |
| Tuesday, January 1, 2019 | 20893000 | 40849000 |
| Wednesday, January 1, 2020 | 25678000 | 60210000 |
| Friday, January 1, 2021 | 29665000 | 83664000 |
| Saturday, January 1, 2022 | 43628000 | 104097000 |
| Sunday, January 1, 2023 | 69135000 | 106916000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Geron Corporation and Iovance Biotherapeutics, Inc. from 2014 to 2023. Over this period, Iovance Biotherapeutics has consistently outpaced Geron Corporation in SG&A spending, reflecting its aggressive growth strategy. In 2023, Iovance's expenses were approximately 55% higher than Geron's, highlighting its commitment to expanding its market presence. Notably, both companies have seen a significant increase in SG&A costs, with Geron experiencing a 312% rise and Iovance a 1045% surge since 2014. This trend underscores the escalating costs associated with innovation and competition in the biotech sector. As these companies continue to evolve, their financial strategies will play a pivotal role in determining their future success.
Pfizer Inc. and Geron Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Geron Corporation
Operational Costs Compared: SG&A Analysis of GSK plc and Geron Corporation
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Geron Corporation
Cost Management Insights: SG&A Expenses for Incyte Corporation and Geron Corporation
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Geron Corporation
Dr. Reddy's Laboratories Limited and Geron Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Opthea Limited vs Geron Corporation
Who Optimizes SG&A Costs Better? CRISPR Therapeutics AG or Geron Corporation
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Geron Corporation and BioCryst Pharmaceuticals, Inc.